Skip to main content
Figure 2 | Critical Care

Figure 2

From: Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis

Figure 2

Expression of IL-6, MCP-1 and RANTES in HUVECs after treatment with LPS and/or bevacizumab. A, cDNA of cytokines and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). B, semi-quantitative IL-6 levels. C, semi-quantitative monocyte chemotactic protein-1 (MCP-1) levels. D, semi-quantitative RANTES (regulated on activation, normal T-cell expressed and secreted) levels. Error bars represent SD. *P <0.01 when compared to lipopolysaccharide (LPS)-only treated human umbilical vein endothelial cells (HUVECs) (n = 4).

Back to article page

Critical Care

ISSN: 1364-8535